US: BÜHLMANN GanglioCombi™ ELISA is for Research Use Only. Not for use in diagnostic procedures. Health Canada Licence: 100436 and 100476 The citation list should be used for information only. Herrendorff R et , 2017: Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen specific treatment option for anti-MAG neuropathy. PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1619386114 DOI: 10.1073/pnas.1619386114
Continue Reading
- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites